Rapid Micro Biosystems, Inc. cash flow to debt ratio of -130.11% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Rapid Micro Biosystems, Inc.'s free cash flow has increased -29.89% from $-45.52M last year to $-31.91M, signaling increasing performance

Rapid Micro Biosystems, Inc.'s debt to equity ratio is 1.32, which means that the company's assets are unhealthy financed, signaling financial risk.

Rapid Micro Biosystems, Inc.'s debt has increased relative to shareholder equity from 0.08 last year to 1.32 today, signaling weakened financials

Rapid Micro Biosystems, Inc. has a net cash position, so leverage is healthy.

Rapid Micro Biosystems, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Rapid Micro Biosystems, Inc.'s profit margin has increased (-12.92%) in the last year from -167.16% to -145.56%, signaling increasing performance

Rapid Micro Biosystems, Inc.'s short-term assets of $61.17M exceed its short-term liabilities of $18.49M

Rapid Micro Biosystems, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Rapid Micro Biosystems, Inc.'s return on equity of -177.04%, is lower than 15.00%, indicating bad performance

Rapid Micro Biosystems, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Rapid Micro Biosystems, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Rapid Micro Biosystems, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Rapid Micro Biosystems, Inc. has negative free cash flow, indicating cash burn

Rapid Micro Biosystems, Inc.'s yearly earnings has decreased 0.50% since last year from $-46.89M to $-47.12M, signaling decreasing performance

Rapid Micro Biosystems, Inc.'s yearly revenue has increased 19.74% since last year from $28.05M to $33.59M, signaling increasing performance

ROIC -119.49% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Rapid Micro Biosystems, Inc.'s 3-year revenue CAGR of 25.15% is positive, indicating growing revenue over the past 3 years

Rapid Micro Biosystems, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Rapid Micro Biosystems, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Rapid Micro Biosystems, Inc. has insufficient data to evaluate this check.

Rapid Micro Biosystems, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Rapid Micro Biosystems, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Rapid Micro Biosystems, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Rapid Micro Biosystems, Inc. has insufficient data to evaluate this check.

Rapid Micro Biosystems, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Rapid Micro Biosystems, Inc. has a price-to-book ratio of 4.53x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Rapid Micro Biosystems, Inc. has a price-to-sales ratio of 2.29x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue